Sponsor Pipeline

Mabsoft Therapeutics (Shanghai) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07644650 Phase 1 Study of MST-168 in Participants With Advanced Solid Malignant Tumors Neoplams Not Yet Recruiting
Get alerts when Mabsoft Therapeutics (Shanghai) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free